The Multiple Sclerosis Journal (MSJ) – the sole official journal of ECTRIMS – is a peer-reviewed international journal that focuses on multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system.
What has the scientific community learned following two years of COVID-19 in the MS community? This editorial highlights research showing the responses of the MS Community to close the gaps of knowledge that COVID-19 has brought to us”.
This ECTRIMS-endorsed publication outlines evidence presented during the 2021 international ECTRIMS Focused Workshop on the risk of infections for MS & neuromyelitis optica spectrum disorder DMTs.
Impact of COVID-19 on Multiple Sclerosis Care and Management: Results from the European Committee for Treatment and Research in Multiple Sclerosis Survey
Journal topics include:
Key series:
Controversies in MS: a series of debates published regularly in the journal since October 2011. Read both sides of the debate on a wide range of key topics.
Topical reviews are amongst MSJ’s most downloaded articles, and are both succinct and up-to-date.
This journal is a member of the Committee on Publication Ethics (COPE). The President of ECTRIMS is co-editor of the Multiple Sclerosis Journal. For further information please visit http://msj.sagepub.com.